[Pharmacological profile and clinical efficacy of minodronic acid hydrate as a new therapeutic agent for osteoporosis]
- PMID: 19749488
- DOI: 10.1254/fpj.134.149
[Pharmacological profile and clinical efficacy of minodronic acid hydrate as a new therapeutic agent for osteoporosis]
Similar articles
-
A review of minodronic acid hydrate for the treatment of osteoporosis.Clin Interv Aging. 2013;8:185-9. doi: 10.2147/CIA.S23927. Epub 2013 Feb 15. Clin Interv Aging. 2013. PMID: 23440003 Free PMC article. Review.
-
[Therapeutic agents for disorders of bone and calcium metabolism: Minodronic acid hydrate].Clin Calcium. 2007 Jan;17(1):18-22. Clin Calcium. 2007. PMID: 17211089 Review. Japanese.
-
Zoledronic acid: a review of its use in the treatment of osteoporosis.Drugs Aging. 2008;25(11):963-86. doi: 10.2165/0002512-200825110-00007. Drugs Aging. 2008. PMID: 18947264 Review.
-
[Minodronic acid hydrate as a new therapeutic agent for osteoporosis].Clin Calcium. 2005 Jan;15(1):9-14. Clin Calcium. 2005. PMID: 15632466 Review. Japanese.
-
[Pharmacological profile and clinical evidence in patients with primary osteoporosis treated with intravenous ibandronate].Nihon Yakurigaku Zasshi. 2014 Jun;143(6):302-9. doi: 10.1254/fpj.143.302. Nihon Yakurigaku Zasshi. 2014. PMID: 24919557 Review. Japanese. No abstract available.
Cited by
-
A review of minodronic acid hydrate for the treatment of osteoporosis.Clin Interv Aging. 2013;8:185-9. doi: 10.2147/CIA.S23927. Epub 2013 Feb 15. Clin Interv Aging. 2013. PMID: 23440003 Free PMC article. Review.